Singapore’s Vasoo Says Challenging to Eradicate Covid-19

Singapore’s Vasoo Says Challenging to Eradicate Covid-19

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the challenges faced by migrant workers in Singapore during the COVID-19 pandemic, focusing on dormitory conditions and the risk of virus transmission. It highlights the testing and tracking measures implemented to manage infections. The video also covers vaccine development, emphasizing safety and efficacy, and addresses concerns about reinfection and virus mutation.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one of the main challenges faced by migrant workers in Singapore regarding COVID-19?

Access to healthcare

High-density living conditions

Lack of employment

Limited access to food

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How often are migrant workers in dormitories tested for COVID-19?

Every three months

Every week

Every two weeks

Once a month

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the purpose of the national database mentioned in the transcript?

To manage healthcare resources

To record employment status

To monitor COVID-19 infections

To track the number of dormitories

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What caused the pause in the AstraZeneca vaccine trial?

Vaccine shortage

An illness in a participant

Regulatory issues

Lack of funding

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is considered a good efficacy rate for a COVID-19 vaccine?

10-20%

30-40%

50-60%

70-80%

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the significance of reinfection cases in the context of COVID-19?

They indicate a failure of vaccines

They are common with all viruses

They show the need for better testing

They highlight the need for ongoing research

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What has Singapore not found in its COVID-19 reinfection studies so far?

New virus strains

Reinfection cases

Significant mutations

Vaccine efficacy